299 related articles for article (PubMed ID: 26139534)
1. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Giordano M; Henin C; Maurizio J; Imbratta C; Bourdely P; Buferne M; Baitsch L; Vanhille L; Sieweke MH; Speiser DE; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
EMBO J; 2015 Aug; 34(15):2042-58. PubMed ID: 26139534
[TBL] [Abstract][Full Text] [Related]
2. c-Maf regulates IL-10 expression during Th17 polarization.
Xu J; Yang Y; Qiu G; Lal G; Wu Z; Levy DE; Ochando JC; Bromberg JS; Ding Y
J Immunol; 2009 May; 182(10):6226-36. PubMed ID: 19414776
[TBL] [Abstract][Full Text] [Related]
3. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
4. Induction and transcriptional regulation of the co-inhibitory gene module in T cells.
Chihara N; Madi A; Kondo T; Zhang H; Acharya N; Singer M; Nyman J; Marjanovic ND; Kowalczyk MS; Wang C; Kurtulus S; Law T; Etminan Y; Nevin J; Buckley CD; Burkett PR; Buenrostro JD; Rozenblatt-Rosen O; Anderson AC; Regev A; Kuchroo VK
Nature; 2018 Jun; 558(7710):454-459. PubMed ID: 29899446
[TBL] [Abstract][Full Text] [Related]
5. Impaired IL-4 production by CD8+ T cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter.
Chen XP; Falkner DH; Morel PA
Eur J Immunol; 2005 May; 35(5):1408-17. PubMed ID: 15832295
[TBL] [Abstract][Full Text] [Related]
6. c-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells.
Hiramatsu Y; Suto A; Kashiwakuma D; Kanari H; Kagami S; Ikeda K; Hirose K; Watanabe N; Grusby MJ; Iwamoto I; Nakajima H
J Leukoc Biol; 2010 Apr; 87(4):703-12. PubMed ID: 20042469
[TBL] [Abstract][Full Text] [Related]
7. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
8. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Induces CD8
Ma X; Bi E; Lu Y; Su P; Huang C; Liu L; Wang Q; Yang M; Kalady MF; Qian J; Zhang A; Gupte AA; Hamilton DJ; Zheng C; Yi Q
Cell Metab; 2019 Jul; 30(1):143-156.e5. PubMed ID: 31031094
[TBL] [Abstract][Full Text] [Related]
10.
Verdeil G
Oncoimmunology; 2016 Feb; 5(2):e1082707. PubMed ID: 27057466
[TBL] [Abstract][Full Text] [Related]
11. SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes.
Hsu CY; Yeh LT; Fu SH; Chien MW; Liu YW; Miaw SC; Chang DM; Sytwu HK
J Clin Invest; 2018 Aug; 128(9):3779-3793. PubMed ID: 30059018
[TBL] [Abstract][Full Text] [Related]
12. c-Maf increases apoptosis in peripheral CD8 cells by transactivating Caspase 6.
Peng S; Wu H; Mo YY; Watabe K; Pauza ME
Immunology; 2009 Jun; 127(2):267-78. PubMed ID: 19476513
[TBL] [Abstract][Full Text] [Related]
13. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
14. UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses.
Toda M; Wang L; Ogura S; Torii M; Kurachi M; Kakimi K; Nishikawa H; Matsushima K; Shiku H; Kuribayashi K; Kato T
Int J Cancer; 2011 Sep; 129(5):1126-36. PubMed ID: 21710495
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
16. Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma.
Grange M; Buferne M; Verdeil G; Leserman L; Schmitt-Verhulst AM; Auphan-Anezin N
Cancer Res; 2012 Jan; 72(1):76-87. PubMed ID: 22065720
[TBL] [Abstract][Full Text] [Related]
17. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.
Kalia V; Sarkar S; Subramaniam S; Haining WN; Smith KA; Ahmed R
Immunity; 2010 Jan; 32(1):91-103. PubMed ID: 20096608
[TBL] [Abstract][Full Text] [Related]
18. Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.
Liao Y; Geng P; Tian Y; Miao H; Liang H; Zeng R; Ni B; Ruan Z
Immunol Invest; 2015; 44(2):147-63. PubMed ID: 25122543
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21-producing c-Maf-expressing CD4+ T cells induce effector CD8+ T cells and enhance autoimmune inflammation in scurfy mice.
Iwamoto T; Suto A; Tanaka S; Takatori H; Suzuki K; Iwamoto I; Nakajima H
Arthritis Rheumatol; 2014 Aug; 66(8):2079-90. PubMed ID: 24719360
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
